Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.
Guan L, Torres-Saavedra PA, Zhao X, Major MB, Holmes BJ, Nguyen NK, Kumaravelu P, Hodge T, Diehn M, Zevallos JP, Holsinger FC, Emami B, Jordan RC, Hayward MC, Sagar SM, Morrison W, Schultz C, Caudell JJ, Jones CU, Bratman SV, Galloway TJ, Ma DJ, Yom SS, Kudrimoti M, Kim HE, Harris J, Le QT, Hayes DN. Guan L, et al. Among authors: yom ss. Clin Cancer Res. 2024 Dec 10. doi: 10.1158/1078-0432.CCR-24-2334. Online ahead of print. Clin Cancer Res. 2024. PMID: 39656603
Dose Planning and Radiation Optimization for Thoracic Conventional, Twice Daily, and Stereotactic Radiation Therapy: A Delphi Consensus From a National Survey of Practitioners.
Weng J, Ryckman J, Katz MS, Saeed H, Estes C, Naqa IE, Moreno A, Yom SS; Dose Planning and Radiation Optimization (Dose-PRO) Consensus Group. Weng J, et al. Among authors: yom ss. Pract Radiat Oncol. 2024 Nov 29:S1879-8500(24)00308-4. doi: 10.1016/j.prro.2024.11.006. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 39615586 Free article.
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial.
Mell LK, Torres-Saavedra PA, Wong SJ, Kish JA, Chang SS, Jordan RC, Liu T, Truong MT, Winquist EW, Takiar V, Wise-Draper T, Robbins JR, Rodriguez CP, Awan MJ, Beadle BM, Henson C, Narayan S, Spencer SA, Powell S, Dunlap N, Sacco AG, Hu KS, Park HS, Bauman JE, Harris J, Yom SS, Le QT. Mell LK, et al. Among authors: yom ss. Lancet Oncol. 2024 Dec;25(12):1576-1588. doi: 10.1016/S1470-2045(24)00507-2. Epub 2024 Nov 14. Lancet Oncol. 2024. PMID: 39551064 Free PMC article. Clinical Trial.
Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic.
Harris AC, Markova A, Devlin S, Singh A, Susman P, Brown S, Grasso C, Custodio C, Estilo C, Ibanez K, Myers M, Syrkin G, Yom S, Perales MA, Ponce DM. Harris AC, et al. Among authors: yom s. Transplant Cell Ther. 2024 Dec;30(12):1215.e1-1215.e11. doi: 10.1016/j.jtct.2024.09.016. Epub 2024 Sep 19. Transplant Cell Ther. 2024. PMID: 39303987
Reply to M. Boileau et al.
Barker CA, Yom SS. Barker CA, et al. Among authors: yom ss. J Clin Oncol. 2024 Nov 10;42(32):3883-3884. doi: 10.1200/JCO-24-01365. Epub 2024 Aug 2. J Clin Oncol. 2024. PMID: 39094069 No abstract available.
312 results